| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849652 1,2,4-triazole derivative or a non-toxic salt thereof as an active ingredient for treatment of fever, pain, and inflammation |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 02/01/2005 | US6849646 Chromenone and chromanone derivatives as integrin inhibitors |
| 02/01/2005 | US6849643 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849638 Phosphodiesterase enzyme 7b (pde7b) inhibitors; treating osteoporosis, osteopenia and asthma |
| 02/01/2005 | US6849637 Matrix metalloproteases (MMPs) inhibitors such as benzyl 4-benzyl-5-oxo-4H-(1,2,4)triazolo(4,3-a)quinazol-7-ylcarboxylate for inflammatory conditions such as rheumatoid arthritis or osteoarthritis, or cancer |
| 02/01/2005 | US6849635 Sulfonamides |
| 02/01/2005 | US6849626 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/01/2005 | US6849625 Use in manufacture of a medicament for use as an anti-invasive agent in containment and/or treatment of solid tumor disease |
| 02/01/2005 | US6849624 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders |
| 02/01/2005 | US6849623 For use as human and veterinary medicine |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 02/01/2005 | US6849612 Oligonucleotide modulation of cell adhesion |
| 02/01/2005 | US6849601 A conotoxin proteins is adrenergic blocking agents, treating disorders of urinary or cardiovascular conditions, having alpha 1-adrenoceptor antagonist activity |
| 02/01/2005 | US6849593 Bifidogenic peptides |
| 02/01/2005 | US6849058 Treating rheumatoid arthritis by administering a photoactive compound such as a porphyrin systemically, directly to an affected joint or extracorporally to blood and irradiating to effect activation; returning blood to body |
| 02/01/2005 | CA2239964C Steroid nitrite ester derivatives useful as anti-inflammatory drugs |
| 01/27/2005 | WO2005007838A1 Cell diffrentiation inhibitor, cell culture method using the same, liquid culture medium and cultured cell line |
| 01/27/2005 | WO2005007650A1 Chemical compounds containing tocopherol and at least one additional pharmaceutical active substance |
| 01/27/2005 | WO2005007629A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 01/27/2005 | WO2005007616A1 Diphenylamino ketone derivatives as mek inhibitors |
| 01/27/2005 | WO2005007169A2 Liposomes containing phosphate glycerol groups for treating acute inflammatory condition |
| 01/27/2005 | WO2005007163A1 Antipruritic agent containing chroman compound as active ingredient |
| 01/27/2005 | WO2005007160A1 Enema preparation |
| 01/27/2005 | WO2005007146A1 Ambroxol for treating chronic nociceptive pains |
| 01/27/2005 | WO2004105785A3 Use of pam |
| 01/27/2005 | WO2004099130A3 1,2-diarylimidazoles useful as inhibitors of cox |
| 01/27/2005 | WO2004092118A3 2-propylidene-19-nor-vitamin d compounds |
| 01/27/2005 | WO2004082580A3 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 01/27/2005 | WO2003087374A9 Derivatives of the il-2 receptor gamma chain, their production and use. |
| 01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
| 01/27/2005 | US20050020837 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 01/27/2005 | US20050020832 For therapy of atherosclerosis |
| 01/27/2005 | US20050020691 Pharmaceutical preparations comprising substituted beta-aminoalcohols |
| 01/27/2005 | US20050020688 Mixing nimesulfide with vinyl glyceol for topical drug for antiinflammatory agents |
| 01/27/2005 | US20050020671 Core comprises first active ingredient, coating comprising second active ingredient incompatible with first and barrier between core and coating which prevents physical contact between them, characterised in that barrier is formed on core by film-coating and coating is formed by press-coating |
| 01/27/2005 | US20050020659 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 01/27/2005 | US20050020657 Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-2 |
| 01/27/2005 | US20050020642 Antiinflammatory agents; antiarthritic agents; anticancer agents; angiogenesis inhibitors; asthma therapy; cyclooxygenase inhibitor |
| 01/27/2005 | US20050020639 Novel compounds |
| 01/27/2005 | US20050020611 Phosphodiesterase inhibitor; antihistamines; antiallergens |
| 01/27/2005 | US20050020592 Substituted heterocyclic compounds and methods of use |
| 01/27/2005 | US20050020585 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 01/27/2005 | US20050020581 4H-quinazolinyl compounds; alkylation of a quinazoline with a 3-bromopiperidine-2,6-dione followed by alkylation with a heterocyclic alkyl compound; immunomodulators with increased solubility and chemical resistance to hydrolysis; alternatives to thalidomide treatment for autoimmune diseases |
| 01/27/2005 | US20050020579 Novel crystalline tricyclic triazolobenzazepine derivative |
| 01/27/2005 | US20050020562 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 01/27/2005 | US20050020551 Using a compound containing gonand ring and a keto group |
| 01/27/2005 | US20050020549 aqueous suspension; rhinitis therapy |
| 01/27/2005 | US20050020541 Moderate neurotransmitters |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020539 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 01/27/2005 | US20050020504 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 01/27/2005 | US20050020500 Glycosaminoglycan-polypeptide complex; antiarthritic agents |
| 01/27/2005 | US20050020498 Apo-2 ligand/trail formulations |
| 01/27/2005 | US20050020481 Ion channel modulating compounds and uses thereof |
| 01/27/2005 | US20050019908 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019433 Negatively charged polysaccharide derivable from aloe vera |
| 01/27/2005 | US20050019426 Use of an aqueous or hydroalcoholic extract from bauhinia for the preparation of a composition |
| 01/27/2005 | US20050019391 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 01/27/2005 | US20050019376 Containing at least one active ingredient and a confectionery composition such as fat, amorphous sugar glass, or fondant; polarized light transmission; especially for pediatric and geriatric applications |
| 01/27/2005 | DE10332281A1 Medicaments for treating inflammatory diseases, especially hemorrhoids, herpes or urinary tract or prostate inflammation, comprises parts or extracts of the plant Amaranthus blitoides |
| 01/27/2005 | CA2533084A1 Liposomes containing phosphate glycerol groups for treating acute inflammatory condition |
| 01/27/2005 | CA2532301A1 Ambroxol for treating chronic nociceptive pains |
| 01/27/2005 | CA2531343A1 Enema preparation |
| 01/27/2005 | CA2496130A1 Chemical compounds containing tocopherol and at least one additional pharmaceutical active substance |
| 01/26/2005 | EP1500698A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport |
| 01/26/2005 | EP1500658A1 Novel thiol derivative, process for producing the same and use thereof |
| 01/26/2005 | EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors |
| 01/26/2005 | EP1500654A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 01/26/2005 | EP1500643A1 Benzamide derivatives |
| 01/26/2005 | EP1500400A1 Drug containing antibody composition |
| 01/26/2005 | EP1500396A1 Reboxetine for treating migraine headaches |
| 01/26/2005 | EP1500395A1 Reboxetine for treating fibromyalgia and other somatoform disorders |
| 01/26/2005 | EP1499729A1 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
| 01/26/2005 | EP1499724A1 Derivatives of the il-2 receptor gamma chain, their production and use |
| 01/26/2005 | EP1499721A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription factors |
| 01/26/2005 | EP1499619A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
| 01/26/2005 | EP1499614A1 Adenosine a3 receptor modulators |
| 01/26/2005 | EP1499613A1 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 01/26/2005 | EP1499611A1 Process for 5- 2(r)- 1(r)- 3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one |
| 01/26/2005 | EP1499605A2 NF-KappaB INHIBITORS |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499599A1 Substituted pyrazine derivatives |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1499589A1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
| 01/26/2005 | EP1499588A1 Melanocortin receptor ligands |
| 01/26/2005 | EP1499585A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 01/26/2005 | EP1499360A2 Formulation comprising buprenorphine |
| 01/26/2005 | EP1499358A1 Ph-sensitive polymer |
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499345A2 Protein a compositions and methods of use |
| 01/26/2005 | EP1499343A1 A method of modulating cellular activity |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499328A1 Methods of treating necrotizing enterocolitis |
| 01/26/2005 | EP1499325A1 Methods and compositions for inhibition of irritation by disaccharide and metal ions |
| 01/26/2005 | EP1499322A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |